CDK1 and neoplasm: PTEN loss results in activation of AKT, CDK1, and CDK2 kinases, which in turn leads to phosphorylation of FOXO1, exclusion of FOXO1 from the nucleus, and loss of the tumor suppressor functions in the nucleus 18, 25-27.